Qiming U.S. Ventures Management as of June 30, 2024
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jasper Therapeutics Com New (JSPR) | 40.1 | $21M | 929k | 22.70 | |
| Korro Bio (KRRO) | 23.7 | $13M | 368k | 33.87 | |
| Tourmaline Bio (TRML) | 18.1 | $9.5M | 742k | 12.86 | |
| Hillevax (HLVX) | 15.4 | $8.1M | 559k | 14.46 | |
| Ventyx Biosciences (VTYX) | 1.8 | $952k | 412k | 2.31 | |
| Kezar Life Sciences (KZR) | 0.9 | $497k | 829k | 0.60 |
